# Effect of a CCK-1R Agonist on Food Intake in Humans

> **NCT00600743** · PHASE2 · TERMINATED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 40 (actual)

## Conditions studied

- Bulimia

## Interventions

- **DRUG:** GSKI181771X (CCK-1R agonist)
- **BEHAVIORAL:** Instructions to binge eat
- **BEHAVIORAL:** Instructions to eat normally
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00600743
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Drug expired before was completed.
- **Last updated:** 2017-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600743, "Effect of a CCK-1R Agonist on Food Intake in Humans". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00600743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*